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The loop-less tmCdc34 E2 mutant defective in
polyubiquitination in vitro and in vivo supports
yeast growth in a manner dependent on Ubp14
and Cka2
Agnieszka Lass1†, Ross Cocklin2†, Kenneth M Scaglione1,3, Michael Skowyra1,4, Sergey Korolev1, Mark Goebl2* and
Dorota Skowyra1*

Abstract
Background: The S73/S97/loop motif is a hallmark of the Cdc34 family of E2 ubiquitin-conjugating enzymes
that together with the SCF E3 ubiquitin ligases promote degradation of proteins involved in cell cycle and
growth regulation. The inability of the loop-less Δ12Cdc34 mutant to support growth was linked to its
inability to catalyze polyubiquitination. However, the loop-less triple mutant (tm) Cdc34, which not only lacks
the loop but also contains the S73K and S97D substitutions typical of the K73/D97/no loop motif present in
other E2s, supports growth. Whether tmCdc34 supports growth despite defective polyubiquitination, or the
S73K and S97D substitutions, directly or indirectly, correct the defect caused by the loop absence, are
unknown.
Results: tmCdc34 supports yeast viability with normal cell size and cell cycle profile despite producing fewer
polyubiquitin conjugates in vivo and in vitro. The in vitro defect in Sic1 substrate polyubiquitination is similar to the
defect observed in reactions with Δ12Cdc34 that cannot support growth. The synthesis of free polyubiquitin by
tm
Cdc34 is activated only modestly and in a manner dependent on substrate recruitment to SCFCdc4.
Phosphorylation of C-terminal serines in tmCdc34 by Cka2 kinase prevents the synthesis of free polyubiquitin
chains, likely by promoting their attachment to substrate. Nevertheless, tmCDC34 yeast are sensitive to loss of the
Ubp14 C-terminal ubiquitin hydrolase and DUBs other than Ubp14 inefficiently disassemble polyubiquitin chains
produced in tmCDC34 yeast extracts, suggesting that the free chains, either synthesized de novo or recycled from
substrates, have an altered structure.
Conclusions: The catalytic motif replacement compromises polyubiquitination activity of Cdc34 and alters its
regulation in vitro and in vivo, but either motif can support Cdc34 function in yeast viability. Robust
polyubiquitination mediated by the S73/S97/loop motif is thus not necessary for Cdc34 role in yeast viability, at
least under typical laboratory conditions.
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Introduction
The covalent attachment of ubiquitin to other proteins
often serves as the signal for their degradation by the 26
S proteasome [1]. Protein ubiquitination depends on a
cascade of ubiquitin transfer reactions that begins with
the formation of a high-energy thiolester between the
C-terminus of ubiquitin and the catalytic site cysteine of
the E1 ubiquitin-activating enzyme. The activated ubiquitin is transesterified to the active site cysteine of one
of many E2 ubiquitin-conjugating enzymes and then
conjugated to specific substrates in a manner dependent
upon specific E3 ubiquitin ligases. While the term “ubiquitin ligase” implies that all E3s are enzymes, only the
HECT-type E3s contain a catalytic site cysteine that
directly participates in the ubiquitin transfer. The
RING-type E3s promote ubiquitination of specific substrates by the catalytic site of an E2. The significance of
this difference is unclear, as both types of ubiquitin
transfer cascades lead to formation of an isopeptide
bond between the C-terminus of ubiquitin and a lysine
residue on the substrate. Protein substrates can be modified with one or multiple ubiquitins and a chain of
polyubiquitin can be synthesized when a lysine of ubiquitin serves as the isopeptide bond acceptor. A chain
involving lysine 48 (K48) of ubiquitin and composed of
at least 4 ubiquitins serves as the primary signal for substrate proteolysis [2,3].
The RING-type SCF E3s are the largest and arguably
most extensively studied family of ubiquitin ligases, with
members present in all eukaryotes [4]. The discovery of
the SCF E3s was initiated by the observation that the S.
cerevisiae CDC34 gene encodes an E2 [5] that together
with the Cdc53, Skp1 and Cdc4 cell cycle regulatory
proteins promote degradation of the Sic1 S-phase
cyclin-dependent kinase inhibitor, thereby permitting
entry into S phase [6,7]. A subsequent biochemical
reconstruction [8-11] showed that Skp1, Cdc53, Rbx1
and Cdc4, an F-box protein, form the SCFCdc4 E3 complex. The large number of F-box proteins with different
C-terminal protein-protein interaction motifs enables
the family of SCF E3s to recruit many substrates for
ubiquitination by Cdc34, usually in response to substrate
phosphorylation.
Of the eleven E2 ubiquitin-conjugating enzymes in S.
cerevisiae, only Cdc34 functions with SCF E3s in vivo.
This specificity is attributed to the unique C-terminus
of Cdc34 that includes a domain necessary for binding
to SCF [12-14], because Cdc34 mutants that lack this Cterminal domain cannot support yeast viability and a
fusion protein containing this domain and the catalytic
core of Rad6 can replace Cdc34 function in vivo. Based
on this evidence it has been proposed that the catalytic
cores of the E2s are interchangeable [15,16].
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On the other hand, three elements, S73, S97 and an
acidic loop, distinguish the E2 cores of Cdc34 and Ubc7
from other ubiquitin conjugating enzymes (Figure 1A)
[17]. The significance of these elements is best illustrated by the lethality associated with the substitution
of residue S97 or deletion of the loop alone (Δ12) [17].
The loop-less Δ12Cdc34 monoubiquitinates the SCFCdc4dependent substrate Sic1 with a rate comparable to the
rate of wild type Cdc34 (0.2 pmol/s) but synthesizes
K48-type di-ubiquitin at a 10-fold slower rate (0.08
pmol/s vs. 0.8 pmol/s). Based on these findings it has
been proposed that the loop plays a key role in the
synthesis of K48-type polyubiquitin [18,19]. Similarly,
the S97D replacement prevents self-association of
Cdc34 molecules [20], a step implicated in the activation
of polyubiquitination [21]. An E2 protein lacking both of
these elements would be predicted to be even more
defective and fail to support yeast growth. Contrary to
this expectation, the S97D substitution and the loop
deletion act as intragenic suppressors, and the suppression is best when combined with the S73K substitution,
which by itself has no phenotype. The resulting triple
mutant (tm) Cdc34 (S73K, S97D, Δ12) has the K73/
D97/Δloop motif typical of other E2s, no longer displays
the self-associating defect typical of the S97D substitution alone and supports the growth of cdc34-2ts mutant
yeast at a non-permissive temperature. A recent genetic
study shows that the tm CDC34 allele supports yeast
growth even when expressed from the natural chromosomal location of CDC34 [22]. However, this gene replacement causes numerous yet not fully understood
changes in gene expression and evokes sensitivity to loss
of several genes, including genes previously linked to
function of the Cdc34/SCF pathway. Among these genes
is CKA2, which encodes the catalytic subunit of casein
kinase 2 that phosphorylates Cdc34 [23,24]; RPN10,
which encodes the classic ubiquitin-binding receptor of
the proteasome; and RAD23, which encodes the UBAUBL type of a shuttle protein that genetically and biochemically interacts with RPN10 [25,26]. One of the key
unanswered questions is whether tmCdc34 supports cell
growth despite compromised polyubiquitination, or the
S73K and S97D substitutions, directly or indirectly, correct the defect in polyubiquitination associated with the
loop absence.
We show that replacement of the catalytic motif compromises polyubiquitination activity of Cdc34 and alters
its regulation in vitro and in vivo. Nevertheless, either
motif can support Cdc34 function in cell growth and
division, with normal cell size and cell cycle profile.
These findings suggest that robust polyubiquitination
catalyzed in a manner dependent on the S73/S97/loop
motif is not necessary for Cdc34 function in vivo, at
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least under typical laboratory conditions. The S73/S97/
loop motif conservation could be associated with a yet
unappreciated role of Cdc34, possibly under conditions
of stress and/or compromised growth.

Results

Isogenic CDC34 and tmCDC34 yeast strains have similar
growth properties, cell size and cell cycle profiles under
typical laboratory conditions

Due to an essential role of Cdc34 in cell division [5],
mutations that compromise Cdc34 function in vivo lead
to cell cycle arrest. Monitoring growth and cell cycle
phenotype is thus a common approach to assess the
role of Cdc34 residues and/or motifs.
Previous analysis of growth phenotypes suggested that
the triple mutant tm Cdc34 in which the S73/S97/loop
motif conserved among the Cdc34-like E2s is replaced
with the K73/D97/no loop motif typical for other E2s
(Figure 1A-D) supports yeast growth. This conclusion
was based on complementation of the cdc34-2 temperature sensitive (ts) and cdc34Δ mutant yeast by over-
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expressed chimeric ch CDC34/RAD6 [16] or triple
mutant tmCDC34 [17]; an approach that could mask a
functional defect due to overproduction of the complementing protein. However, we obtain similar results
when cdc34-2ts yeast express the tmCDC34 allele from
the GAL1 promoter under non-inducing conditions
thereby ensuring only low level expression (Figure 1E).
In contrast, growth is not supported by S97DCDC34 that
carries only the S97D replacement, or by Δ12CDC34 that
lacks the loop alone. Disruption of the S73/S97/loop
motif in Cdc34, but not its replacement with the alternative E2 core motif is thus lethal for yeast.
We next generated a yeast strain in which the wildtype ORF region of CDC34 is replaced by an ORF
encoding tmCdc34, leaving the 5’ and 3’ regions intact
[22]. The integration of tmCDC34 at the natural chromosomal locus of CDC34 supports yeast growth on
plates (Figure 2A) and in liquid culture (Figure 2B). In
liquid growth medium CDC34 (BL2) yeast have an estimated doubling time of 86 +/-2 min and tm CDC34
(RC85) yeast double every 92 +/- 4 minutes. Apart from

Figure 1 Disruption, but not replacement, of the S73/S97/loop motif conserved among the Cdc34/Ubc7 E2 family is lethal for yeast.
(A). Partial sequence alignment. Asterisks represent residues identical to Cdc34 and dashes represent gaps. Sc - S. cerevisiae; Oc - O. cuniculus;
Dm - D. melanogaster; Ce - C. elegans; At - A. thaliana; Hs - H. sapiens; ASFV1 - African swine fever virus (GI:9628248); ASFV2 -African swine fever
virus (GI:450743). (B). Structural models of the E2 core (a.a. 1-170) of Cdc34 and tmCdc34. Residues corresponding to K73 and D97 in tmCdc34,
and S73 and S97 in Cdc34, are color coded as in A and shown in the context of structures of a scRad6 and scUbc7 fragment (Methods); navy
blue: the acidic loop formed by scUbc7 residues corresponding to amino acids 103-114 in Cdc34; red: the residue corresponding to the catalytic
site C95 of Cdc34 and tmCdc34. (C). Model of ubiquitin-charged Cdc34 (a.a. 1-170) bound to the RING domain of Rbx1. See Methods. (D).
Scheme of Cdc34 domains of interest. (E). Rescue of cdc34-2ts yeast growth with Cdc34 E2 core mutant constructs. Cultures of cdc34-2ts strain
carrying the indicated constructs under the GAL10 promoter on a 2μ YEp51 plasmid were grown overnight at 27°C in SD-Leu, adjusted to a
density of 1 × 108 cells/ml, serially diluted, spotted onto SD-Leu plates and incubated at permissive (27°C) or non-permissive (37°C) temperature
for 4 days. Note that dextrose allows only low expression of the GAL10 controlled constructs.
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Figure 2 Isogenic CDC34 (BL2) and tmCDC34 (RC85) yeast strains have similar growth properties, cell size and cell cycle profiles under
typical laboratory conditions. (A). Growth on plates. Overnight cultures were adjusted to a density of 1 × 108 cells/ml, serially diluted, spotted onto
YPD and grown at 30°C. (B). Growth in liquid culture. Each strain was inoculated in three biological replicates into pre-warmed 50 ml of YPD at a
starting density of 5 × 105 cells/ml and grown with vigorous shaking at 31.5°C. The doubling time for CDC34 (BL2) is 86 +/- 2 min and tmCDC34 (RC85)
is 92 +/- 4 minutes during the exponential phase of growth (0-11.75 hrs). (C). Light microscopic images of cells. Yeast cultures were grown as in B, with
images collected at 1.5 × 107 cells/ml (mid-log phase) and 2 × 108 cells/ml (stationary phase). (D). Cell cycle distributions. Yeast cells were analyzed by
flow cytometry for their DNA content using propidium iodide staining (Methods). (E). Quantitative western blot analysis of the steady-state levels of
Cdc34 and tmCdc34 proteins. Yeast extracts were prepared as described in Methods. The indicated amounts of total proteins were separated by SDSPAGE and analyzed by a-Cdc34 WB. Control a-Skp1 WB was performed to verify equal loading of analyzed samples. Known amounts of purified
Cdc34 and tmCdc34 were used to verify that the a-Cdc34 antibodies have similar affinity for each protein construct.

this modest difference, these strains have similar cell
size and budding profiles, and accumulate to similar cell
densities in stationary phase (Figure 2C). Analysis of
DNA isolated from dividing CDC34 (BL2) and tmCDC34
(RC85) yeast verifies that they have similar cell cycle
profiles under typical laboratory conditions (Figure 2D).
These findings verify that tmCdc34 protein supports
yeast growth despite lacking the catalytic core elements
conserved among the Cdc34-like E2s. However, the
steady-state level of tmCdc34 protein in yeast extracts is
approximately 4-fold higher than the level of Cdc34
(Figure 2E) even when extracts are prepared by boiling
cells directly in SDS-PAGE loading buffer (data not
shown). Since the increased steady-state level of
tm
Cdc34 is seen in a strain isogenic to the CDC34
strain, the difference is likely due to a difference in
post-translational regulation associated specifically with
the replacement of the catalytic E2 motif.
Purified tmCdc34 forms an ubiquitin-thiolester and
monoubiquitinates substrates, but is defective in
substrate polyubiquitination

To address how tmCdc34 functions without the catalytic
core elements conserved among the Cdc34-like E2s, we

compared the various activities of purified tmCdc34 to
the activities of wild type Cdc34 and loop-less Δ12Cdc34.
The comparison of Cdc34 and tmCdc34 was done with
full-length proteins, but the comparison of all three catalytic cores (wt, tm, Δ12) could be performed only with
Cdc34 proteins terminated at residue 244 (Figure 1D)
because full-length Δ12 Cdc34 is insoluble (this work).
The previous characterization of Δ12 Cdc34 was also
done with a C-terminally truncated mutant
(Δ12Cdc34270) [18]. Ectopic expression of Cdc34244 rescues growth of cdc34Δ yeast [15,16,27] and supports
yeast viability when expressed from the chromosomal
location of CDC34 [28], demonstrating that the C-terminally truncated form of Cdc34 is functional, at least in
the context of the wild type E2 core. All Cdc34 proteins
used in this study elute as monomers in gel filtration
chromatography (data not shown).
We first tested the ability of the purified Cdc34 244 ,
Δ12
Cdc34244 and tmCdc34244 proteins to form ubiquitinthiolester. Cdc34 molecules charged with an ubiquitin
thiolester are stable only under conditions preventing
ubiquitin discharge. Those conditions are ensured by
the absence of SCF, substrate and several C-terminal
lysines in Cdc34 that serve as intramolecular substrates
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(Figure 1D) [28]. The charging was performed for a
short time (5 minutes) with 1 pmol of Uba1 E1 and 1-4
pmol of Cdc34244, Δ12Cdc34244 or tmCdc34244 followed
by SDS-PAGE under either non-reducing conditions (to
preserve the thiolester bond) or reducing conditions (to
verify that the ubiquitin-thiolester is sensitive to reduction). The charging was not allowed to proceed to completion, thereby ensuring that we could detect an
increase or decrease in the percentage of ubiquitincharged E2 molecules. Under these assay conditions,
similar fractions (10-50%) of total Cdc34244, Δ12Cdc34244
and tmCdc34244 molecules are converted into ubiquitinthiolesters within a range of protein concentrations (Figure 3A). This result agrees with a previous finding that
Δ12
Cdc34270 forms an ubiquitin-thiolester similarly to
wild type Cdc34 [18]. Neither the loop deletion nor the
triple mutant alteration of the E2 core thus compromises formation of the ubiquitin-thiolester.
We next tested the ability of full-length Cdc34 and
tm
Cdc34 to autoubiquitinate one of their C-terminal
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lysines (Figure 1D). This reaction is inefficient and it is
catalyzed only in the absence of SCF [28]. However,
due to the intra-molecular nature [28], autoubiquitination provides unique insight into the intrinsic function
of Cdc34. We find that autoubiquitination of fulllength tm Cdc34 is compromised (Figure 3B, a-Cdc34,
compare lanes 6-9 and 1-5). The lack of high molecular weight species in reactions with wild type ubiquitin
is consistent with a defect in polyubiquitination of
monoubiquitinated tm Cdc34, as it resembles the pattern observed with methylated ubiquitin that cannot
be incorporated into polyubiquitin (Figure 3B, aCdc34, compare lanes 6-9, 11-14, and 15-18). However,
longer reaction times are also needed to detect monoubiquitinated tm Cdc34 in amounts similar to Cdc34
(Figure 3B, a-Cdc34, lanes 11-14 and 15-18). Furthermore, the intra-molecular nature of autoubiquitination
[28] does not allow this assay to discriminate between
catalytic defects or a change in the intra-molecular
contacts between the E2 C-terminus and the E2 core.

Figure 3 Purified tm Cdc34 forms ubiquitin thiolester and monoubiquitinates substrates, but is defective in substrate
polyubiquitination. All assays were performed at 25°C in 10-20 μL and included 1 pmol of Uba1 E1 and 1.3 nmol of ubiquitin or its derivative.
(A). Formation of ubiquitin-thiolester. The indicated Cdc34244 proteins with wt, tm or Δ12 E2 core (1-4 pmol) were incubated for 5 minutes with
Uba1 and ubiquitin followed by SDS-PAGE under reducing (+ bME) or non-reducing (- bME) conditions and a-Cdc34 WB. (B). Autoubiquitination
of full length Cdc34 and tmCdc34. Full length Cdc34 or tmCdc34 (5 pmol) was incubated for the times indicated with Uba1 and ubiquitin or
methylated ubiquitin followed by a-Cdc34 WB. (C). FSCFCdc4-dependent polyubiquitination of Sic1. The indicated Cdc34244 proteins (5 pmol)
were incubated for the times indicated with Uba1, the Sic1/Clb5/GstCdc28 substrate complex (2 pmol) and FSCFCdc4 (2 pmol) followed by 10%
SDS-PAGE and a-Sic1 WB. Reactions shown in lanes 4, 8 and 12 do not have Sic1. (D). GstSCFMet30-dependent polyubiquitination of Met4. Tests
were performed as described in C except that with the GstSCFMet30 E3 and FMet4 substrate. (E). GstSCFMet30-dependent monoubiquitination of
F
Met4. Tests as in D, but analyzed with shorter (1 instead of 5 minutes) western blot exposure time, which is necessary to visualize
unubiquitinated and monoubiquitinated FMet4 as separate species due to similarities in their molecular weights.
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The altered pattern of autoubiquitination nevertheless
provides evidence of a profound intrinsic (independent
of SCF) difference between the activities of tm Cdc34
and Cdc34.
We next sought to analyze the activity of tmCdc34 in
the presence of SCF E3. We obtained similar results
with full-length tm Cdc34 and C-terminally truncated
tm
Cdc34244. However, only in experiments with C-terminally truncated proteins terminated at residue 244
could we compare the activities of tmCdc34 and Cdc34
to the activity of Δ12Cdc34 due to the poor solubility of
full-length Δ12Cdc34. In SCFCdc4-dependent assays with
tm
Cdc34244, high molecular weight species of the Sic1
substrate (indicative of its polyubiquitination; Sic1-Ubn)
are visualized via western blot with a-Sic1 antibodies
only after long incubation times, exceeding by at least 12fold (> 60 vs. 5 min) the time necessary to detect Sic1
modified by Cdc34 244 (Figure 3C, lanes 5-8, 1-4).
tm
Cdc34244 is as defective as Δ12Cdc34244 in the formation
of high molecular weight Sic1 species and both mutant
E2s catalyze a similar accumulation of Sic1 monoubiquitinated on one (Sic1-Ub1) or two (Sic1-Ub2) lysines (Figure
3C, lanes 5-8, 9-12 and data not shown). Monoubiquitination of additional lysines on Sic1 can be observed in the
presence of high Cdc34 concentrations (1-3 μM;
[8,9,29,30]) that exceed by about 10-fold the estimated
concentration of Cdc34 in cells [31]. We also tested polyubiquitination of FMet4, the SCFMet30-dependent substrate
modified on a single lysine residue K163 in vivo [32] and
in vitro [33]. Western blot with a-Flag antibodies visualizes polyubiquitinated forms of FMet4 after 5 minutes of
reaction with Cdc34244, but 30 minutes are needed for
similar polyubiquitination by tmCdc34244, suggesting a rate
at least 6-fold slower (Figure 3D; a-FMet4, lanes 1-5 and
6-10, FMet4-Ubn). In contrast, western blot with a-Flag
antibodies does not detect polyubiquitinated FMet4 even
after 60 minutes of incubation with Δ12Cdc34244 (Figure
3D; a-FMet4, lanes 11-15, FMet4-Ubn), suggesting that
Δ12
Cdc34244 is less active than tmCdc34244. This difference
reflects a difference in the synthesis of polyubiquitin chain
on monoubiquitinated F Met4, as monoubiquitinated
F
Met4 appears with a similar rate in reactions with
tm
Cdc34244 and Δ12Cdc34244 (Figure 3E; due to similarities
of the apparent molecular weights, unubiquitinated and
monoubiquitinated forms of FMet4 are detectable as separate species only under short western blot exposure
times). This observation agrees with the finding that deletion of the loop does not affect substrate monoubiquitination by Cdc34 [18].
In summary, tmCdc34 is normally charged with ubiquitin thiolester and monoubiquitinates substrates in a
manner similar to wild type Cdc34 and Δ12Cdc34. However, either the loop deletion or the motif replacement
compromises substrate polyubiquitination by Cdc34.
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Unlike in reactions with Cdc34, SCFCdc4 stimulates the
synthesis of free polyubiquitin chains by tmCdc34 only
modestly and in a manner dependent on substrate
recruitment

We next addressed how the defect in substrate polyubiquitination by tmCdc34 relates to the synthesis of free
polyubiquitin chains in vitro. The in vitro synthesis of
free polyubiquitin chains by wild type Cdc34 is an
acknowledged aspect of its function [18,21,34-36].
We first tested the accumulation of free polyubiquitin
chains under conditions of a standard ubiquitination
assay with wild type Cdc34 and SCFCdc4. Western blot
analysis performed with antibodies specific to ubiquitin
detects large amounts of high molecular weight polyubiquitin conjugates in the absence but not presence of the
Sic1 substrate (Figure 4A, a-Ub WB, lanes 4 and 3).
Only the more sensitive western blots with a-Sic1 and
a-Cdc34 antibodies can visualize the low amounts of
polyubiquitinated Sic1 and Cdc34 present in the same
reaction mixtures (Figure 4A, a-Sic and a-Cdc34 WBs).
The polyubiquitin conjugates detectable with a-Ub antibodies cannot represent polyubiquitinated Sic1 because
they appear in mixtures lacking Sic1 (Figure 4A, compare a-Ub and a-Sic1 WB, lane 4). The polyubiquitin
conjugates detectable with a-Ub antibodies cannot
represent polyubiquitinated Cdc34, as similar amounts
of polyubiquitinated Cdc34 are detectable in the mixtures containing or lacking these conjugates (Figure 4A,
compare a-Ub and a-Cdc34 WB, lanes 3 and 4). To
verify that these species represent free polyubiquitin
chains, we tested whether they are sensitive to Isopeptidase T (IsoT), which disassembles polyubiquitin chains
in a manner dependent on the free C-terminus [37].
Most of the conjugates that are detectable by western
with a-Ub antibodies disappear upon incubation with
IsoT (Figure 4B; a-Ub WB, lanes 1-4), verifying that
they represent free polyubiquitin chains. Wild type
Cdc34 thus synthesizes super-stoichiometric amounts of
free polyubiquitin chains in the presence of SCFCdc4 and
substrate recruitment prevents this process, presumably
by re-directing the polyubiquitination activity to
substrate.
In contrast, SCF Cdc4 stimulates the synthesis of free
polyubiquitin by tmCdc34 only modestly and in a manner
dependent on the Sic1 substrate (Figure 4A, a-Ub WB,
compare lane 7 and 8). The ubiquitin conjugates detectable with a-Ub antibodies in reactions with tm Cdc34
likely represent free polyubiquitin chains, because the
same a-Ub western blot conditions prevent detection of
substrate-attached polyubiquitin chains in reactions even
with the more active Cdc34 (described above). We did
not verify that the high molecular weight ubiquitin conjugates visualized by a-Ub western blot in tm Cdc34dependent reactions are sensitive to IsoT, because the
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Figure 4 The synthesis of free polyubiquitin chains in vitro and in vivo. (A). Regulation of free polyubiquitin chain synthesis by substrate
recruitment to SCFCdc4. Standard ubiquitination reactions with Cdc34 or tmCdc34 (5 pmol) were analyzed by western blots with a-Ub, a-Sic1 or
a-Cdc34 antibodies. (B). IsoT sensitivity. Reactions as in A lanes 4 and 8 were analyzed for IsoT sensitivity (Methods). (C). Levels of ubiquitin and
ubiquitin conjugates in vivo. Boiled cell extracts (Methods) were analyzed by western blot with a-Ub (Covance) or a-Rpn10 antibodies. Lane 4:
200 ng of free polyubiquitin chains Ub1-6 purchased from Enzo. (D). Growth of tmCDC34 but not CDC34 yeast is sensitive to loss of UBP14.
Haploids with the indicated genotypes were selected on haploid selection media with G418 and nourseothricin at 30°C for three days. (E).
Overexpression of Ubp14 but not Ubp15C354A supports growth of tmCDC34 upb14Δ yeast. Heterozygous diploids (RC171 and RC172) were
transformed with the indicated plasmids that overexpress Ubp14 (pUBP14) or Ubp14C354A (pUBP14-C354A), patched onto sporulation media and
incubated at 26°C for five days. Haploids with the indicated genotypes were selected as in D. (F). Accumulation of ubiquitin conjugates in yeast
extracts enriched with Uba1, ubiquitin, ATP and MgCl2. Extracts with active ubiquitin-proteasome system (10 μg of total proteins; see Methods)
were enriched with Uba1 (10 pmol), ubiquitin (1.3 nmol) ATP (2 mM) and MgCl2 (2 mM), incubated at 25°C for the times indicated and analyzed
by 10% or 18% SDS-PAGE followed by a-Ub (Sigma) or a-Rpn10 WB.

necessity for additional dilution in preparation for IsoT
treatment (see Methods) prevents their detection.
In summary, Cdc34 synthesizes super-stoichiometric
amounts of free polyubiquitin in the presence of
SCFCdc4 and substrate recruitment is sufficient to prevent this process. This regulatory mechanism is disrupted in reactions with tm Cdc34, which synthesizes
fewer free polyubiquitin chains and in a manner dependent on, not attenuated by, substrate recruitment.

tm

CDC34 cells have fewer polyubiquitin conjugates in
vivo, but their disassembly depends on the Ubp14 Cterminal ubiquitin hydrolase

To test whether tmCdc34 protein is defective in ubiquitin conjugation in vivo, we first performed western blot
analysis with a-ubiquitin antibodies of whole cell
extracts prepared by direct boiling of tmCDC34 cells in
SDS-PAGE loading buffer. This procedure leads to rapid
denaturation of proteins, including proteasome and
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ubiquitin proteases, and is therefore likely to extract
intact ubiquitin conjugates. In these experiments,
tm
CDC34 cells have fewer ubiquitin conjugates of a
broad molecular weight than CDC34 cells (Figure 4C,
10% PAGE, lanes 1 and 2; Ub4-Ubn). This difference is
not accompanied by an accumulation of short polyubiquitin chains and the levels of ubiquitin are similar in
both extracts (Figure 4C, 18% PAGE, lanes 1 and 2;
Ub2-4; Ub1). The control western blot performed with
a-Rpn10 antibodies verifies that equal amounts of total
proteins were analyzed (Figure 4C, a-Rpn10). A reduction in ubiquitin conjugates but not ubiquitin levels is
thus detected by analysis of the total ubiquitin conjugates in tmCDC34 yeast.
The patterns of ubiquitin conjugates detectable in
CDC34 and, to a lesser degree, in tm CDC34 cells are
similar and involve species of various molecular
weights (Figure 4C, 10% PAGE, lanes 1 and 2; Ub 4 Ub n ). To assess whether these species represent ubiquitin conjugated to substrates or free polyubiquitin,
we sought to test how their pattern changes upon
deletion of the UBP14 gene, which encodes the only
yeast ubiquitin hydrolase that disassembles polyubiquitin in a manner dependent on the free C-terminus
[37,38]. In the absence of UBP14, free polyubiquitin
species would be expected to accumulate in the form
of short chains composed of 2-6 ubiquitins, as only
longer chains are efficiently disassembled by other
DUBs, while the pattern of ubiquitin conjugated to
substrates should not change unless the levels of free
ubiquitin drop [38]. The high molecular weight ubiquitin conjugates (Ub n ) detectable in extracts prepared
from CDC34 yeast are poorly detectable in extracts
prepared from CDC34 upb14Δ yeast (Figure 4C, 10%
SDS-PAGE, Ubn, lanes 1 and 3). The loss of ubiquitin
conjugates correlates with an appearance of short Ub26 chains but not a change in ubiquitin level (Figure 4C,
18% SDS-PAGE, Ub2-6, Ub1, lanes 1 and 3). Free polyubiquitin chains thus represent a prominent fraction of
the total ubiquitin conjugates in wild type yeast, at
least during vigorous growth. A more accurate estimation is not possible based on these data alone, because
western blot detection is not quantitative and the
available a-ubiquitin antibodies have different affinities
to short and long polyubiquitin chains.
If a significant fraction of the total ubiquitin conjugates detectable in CDC34 yeast extracts are free polyubiquitin chains, the lower level of similarly sized
ubiquitin conjugates in tmCDC34 yeast (Figure 4C, 10%
SDS-PAGE, lanes 1 and 2) could indicate that tmCDC34
yeast have fewer free polyubiquitin chains of similar
lengths. In this case, fewer short Ub 2-6 conjugates
should be detectable in tmCDC34 cells lacking UPB14.
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Unexpectedly, this simple prediction could not be
tested, because unlike wild type yeast, which are viable
in the absence of UBP14, the tmCDC34 ubp14Δ double
mutant yeast are inviable (Figure 4D, tmCDC34 upb14Δ
and CDC34 upb14Δ). This lethality is corrected by ectopic expression of Ubp14 but not an inactive Ubp14
C354A mutant (Figure 4E), verifying the requirement
for Ubp14 function. Thus, tm CDC34 cells have fewer
polyubiquitin conjugates in vivo, but these conjugates
can be disassembled only by Ubp14.
To get an insight into the Ubp14 dependence, we prepared cell extracts in a manner retaining activity of the
ubiquitin-proteasome system (Methods). This procedure
is more time consuming than extraction by cell boiling
and does not include protease inhibitors. The extracts
therefore do not retain the ubiquitin conjugates that
were present in cells prior to lysis, leading to similarly
low backgrounds in the isogenic CDC34 and tmCDC34
yeast, and in the isogenic UBP14 and ubp14Δ yeast
(data not shown). Instead of inhibiting DUBs, we then
attempted to overwhelm their activity by supplementing
the extracts with purified Uba1, Ub, ATP and MgCl 2,
which should maximize the ubiquitin conjugation activities of E2s and E3s in the extracts. As expected, the
supplementing components alone are insufficient to
conjugate ubiquitin (Figure 4F, a-Ub, lanes 5, 10, 15,
20), but stimulate an accumulation of similar amounts
of ubiquitin conjugates in the control extracts prepared
from CDC34 yeast, or the isogenic UBP14 or ubp14Δ
yeast (Figure 4F, 10% PAGE, a-Ub, lanes 1-5, 11-15 and
16-20). We have thus created conditions under which
the lack of Ubp14 activity plays no major role in the
accumulation of high molecular weight ubiquitin conjugates. Under these conditions, more of high molecular
weight ubiquitin conjugates accumulate in tm CDC34
yeast extract (Figure 4F, a-Ub WB, 10% PAGE, Ub n ,
lanes 1-5, 6-10, 11-15 and 16-20). This effect is repetitive and the control western blot with a-Rpn10 antibodies verifies that equal amounts of total proteins were
analyzed (Figure 4F, a-Rpn10).
It cannot be excluded that the 4-fold higher levels of
tm
Cdc34 protein (Figure 2E) plays a role in the abnormal accumulation of high molecular weight ubiquitin
conjugates in tm CDC34 yeast extract. However, this
interpretation would be inconsistent with the defective
function of tm Cdc34 in vivo (Figure 4C, lanes 1, 2). A
more likely explanation is that the polyubiquitin conjugates accumulate due to a delay in their disassembly by
DUBs other than Ubp14. If a similar delay characterizes
the polyubiquitin conjugates synthesized in tmCDC34
cells, their disassembly could be primarily dependent on
C-terminal hydrolysis, explaining the essential role of
Ubp14.
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Phosphorylation of C-terminal serines in tmCdc34 by Cka2
kinase eliminates the synthesis of free polyubiquitin
chains, likely by stimulating their attachment to substrate

Among the genes recently identified as essential for
growth of tmCDC34 but not CDC34 yeast is CKA2 [22]
that encodes the catalytic subunit of casein kinase 2
implicated in Cdc34 function [23,24]. To address how
Cka2 affects tm Cdc34 activity, we first tested whether
Gst
Cka2, or its homologue GstCka1, purified from yeast
can phosphorylate Cdc34 and tm Cdc34 in vitro, and
whether the in vitro phosphorylation of Cdc34 or
tm
Cdc34 is limited to the most C-terminal serines [23]
(Figure 5A, red), or also targets the catalytic E2 core
[24] (Figure 5A, bold black).
Deletion of the C-terminus (Figure 5B, lanes 1-4), or
replacement of the six C-terminal serines with alanines
(Figure 5B, 6SA; lanes 5-10) prevents phosphorylation of
Cdc34 by Gst Cka1. Extended autoradiogram exposure
times are required to detect phosphorylation of the
Cdc346SA mutant and this level of phosphorylation is comparable to the control phosphorylation of BSA (Figure 5B,
lanes 5-10, 4 and 17 days). Only the six most C-terminal
serines are thus phosphorylated within full length Cdc34.
Charging Cdc34 with an ubiquitin thiolester under
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conditions that prevent discharge also does not trigger
phosphorylation of the E2 core (data not shown).
Similarly, Gst Cka2 phosphorylates the six most Cterminal serines in Cdc34 (data not shown), or the two
most C-terminal serines S207 and S216 in Cdc34 244
over a range of concentrations Figure 5C, lanes 1-8).
Gst
Cka2 phosphorylates Cdc34244 and tmCdc34244 with
similar kinetics (Figure 5C, lanes 9-16), suggesting that
the phosphorylation is not affected by the motif replacement. We do not observe phosphorylation of the control
Rad6 E2 even under conditions of 50-fold greater sensitivity of [32P] detection (Figure 5C, lane 21), verifying
that GstCka2 function is specific to Cdc34. Only under
conditions of such sensitivity, we could detect a low
level of phosphorylation of Cdc34244 or tmCdc34244 carrying the S207A and S216A substitutions (Figure 5C, 43
h, lanes 18, 20). This signal represents ~1% of that associated with phosphorylation of S207 and S216 (Figure
5C, lanes 17, 19 and graph), does not account for quantitative phosphorylation of any other two serines, and
was not observed with full-length Cdc346SA protein (Figure 5B, lanes 5-10).
Phosphorylation of tmCdc34 by GstCka2 kinase modestly stimulates the SCFCdc4-dependent ubiquitination of

Figure 5 Yeast GstCka1 or GstCka2 kinases phosphorylate only the most C-terminal serines in Cdc34 and tmCdc34. (A). Scheme of Cdc34.
Red: the six most C-terminal serines. Residue 244 represents the C-terminal end in Cdc34244 that includes the E2 catalytic core (a.a. 1 to 170)
with the active site cysteine C95, the E3 RING domain-interacting fragment, and the 39 a.a. C-terminal fragment (a.a. 171-209) also implicated in
binding to SCF. (B). In a physiological range of protein concentrations, yeast GstCka1 phosphorylates only the six most C-terminal serines within
Cdc34. 1 hour assays included 10 μM ATP with 0.1 μ Ci of [g-32P]ATP (4500 Ci/mmol), 1 pmol of the indicated Cdc34 constructs and 0.5 or 2.5
pmol of GstCka1. (C). GstCka2 phosphorylates the S207 and S216 most C-terminal serines in Cdc34244 and tmCdc34244. Assays were performed for
1 hour (or as indicated), with 5 pmols (or as indicated) of the indicated constructs, 1pmol of GstCka1 kinase and 10 μM ATP with 5 μCi [32P] ATP
(4500Ci/mmol), leading to ~50-fold higher sensitivity of [32P] detection than in B. Graph: quantitation of the [32P] signal of the proteins at
different autoradiogram exposure times. CB: Coomassie blue.

Lass et al. Cell Division 2011, 6:7
http://www.celldiv.com/content/6/1/7

the Sic1 substrate (Figure 6A a-Sic1 WB, compare lanes
1-4 and 5-8). This effect leads to a nearly normal accumulation of polyubiquitinated Sic1 species in 60 minutes, which is a long reaction time (Figure 6A, a-Sic1
WB, lanes 7, 11 and 15). However, even in the presence
of GstCka2 fewer polyubiquitinated Sic1 species accumulate in short reactions with tm Cdc34 than with Cdc34
(Figure 6A, a-Sic1 WB, compare lanes 6, 10 and 14).
The short reaction times are critical because they represent the time in which substrate degradation needs to
be catalyzed in vivo. Cka2 thus stimulates, but does not
fully rescue, the defective polyubiquitination activity of
tm
Cdc34. This observation agrees with the finding that
tm
CDC34 yeast, which have active Cka2, accumulate
fewer polyubiquitin conjugates than CDC34 yeast (Figure 4C, lanes 1 and 2).
The stimulation of Sic1 substrate polyubiquitination
by GstCka2 correlates with a loss of free polyubiquitin
chains in the same reaction mixtures (Figure 6A, a-Ub
WB, compare lanes 3 and 7, arrows; see Figure 4A and
4B for verification that under the conditions used a-Ub
western blot visualizes only free polyubiquitin chains).
Phosphorylation of C-terminal serines in tmCdc34 thus
may eliminate the synthesis of free polyubiquitin chains
by promoting their attachment to substrate. To assess
which of these effects plays a role in vivo, we tested
whether overexpression of the Ubp14 C-terminal hydrolase rescues viability of tmCDC34 cka2Δ yeast. Overexpression of Ubp14 or its catalytically inactive mutant
does not support growth of tmCDC34 cka2Δ yeast (Figure 6B), suggesting that the requirement for Cka2 function is not associated with its role in preventing the free
polyubiquitin chain synthesis. Rather, it reflects the role
in the stimulation of substrate polyubiquitination.
In control reactions with wild type Cdc34, Gst Cka2
has no effect on the SCF Cdc4 -dependent polyubiquitination of Sic1 substrate (Figure 6A, a−Sic1 WB, compare lanes 9-11 and 13-15). However, GstCka2 prevents
the synthesis of free polyubiquitin chains in substratefree reactions with SCF Cdc4 (Figure 6A, a-Ub WB,
lanes 12 and 16, green arrows). This effect is detectable only in substrate-free reactions, excluding the possibility that it results from redirecting the synthesis of
polyubiquitin chains to substrate. Rather, it reflects a
mechanism aimed at inhibiting the unproductive ubiquitin conjugation to free polyubiquitin chains typical
of Cdc34 function with substrate-free SCFs. Under
conditions of in vitro assays performed with low concentration of ubiquitin, or with an access of SCF Cdc4
over substrate, this regulatory effect could indirectly
promote substrate polyubiquitination by preventing
rapid depletion of free ubiquitin. These possibilities
could explain why under some experimental conditions
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the phosphorylation of wild type Cdc34 could stimulate Sic1 polyubiquitination [23].

Discussion
Robust polyubiquitination activity is thought to be key
to the function of the Cdc34 ubiquitin-conjugating
enzyme that, together with the SCF ubiquitin ligases,
promotes degradation of proteins involved in cell cycle
and growth regulation. However, we find that the
tm
Cdc34 protein in which the S73/S97/loop motif is
replaced with the K73/D97/no loop motif typical of
other E2s supports yeast growth with normal cell size
and cell cycle profile despite producing fewer polyubiquitin conjugates in vitro and in vivo. The significance
of this finding comes from the observation that the in
vitro defect in Sic1 substrate polyubiquitination by
tm
Cdc34 is similar to the defect of Δ12 Cdc34 protein
that cannot support growth, and that tm CDC34 yeast
contain fewer polyubiquitin conjugates in vivo than
CDC34 yeast, despite 4-fold higher steady-state levels of
tm
Cdc34 protein. While several cofactors are implicated
in the function of tmCdc34 in vivo [22], these cofactors
thus do not ensure normal ubiquitin conjugation in
tm
CDC34 yeast.
If robust polyubiquitination is not necessary for Cdc34
function in vivo, a yet undefined aspect of the SCF-proteasome pathway would be expected to promote substrate proteolysis under conditions of compromised
polyubiquitination. In support of this possibility,
tm
CDC34 yeast are sensitive to loss of the RPN10 and
RAD23 genes [22] that encode ubiquitin-binding receptors of the proteasome implicated in Sic1 degradation
[25,26]. If SCF Cdc4 indeed directly interacts with the
proteasome, as one study suggests [39], this interaction
could localize tmCdc34 and substrate to the proximity of
the Rpn10 and/or Rad23, thereby compensating for the
lack of robust polyubiquitination. This model is outlined
in Figure 7. However, it cannot be excluded that the
defect in tm Cdc34 is corrected at the proteasome: for
example, in a manner dependent on the ubiquitin-interacting motif (UIM) of Rpn10 recently implicated in
polyubiquitination [40,41]. An insight into which of
these models reflects tm Cdc34 function in tm CDC34
yeast could come from analysis of the kinetic properties
(Km and kcat) of tmCdc34 protein in vitro, and from testing how Rpn10, and Rad23, individually or as part of
the proteasome, affect these properties.
The observation that the catalytic E2 core motifs
define distinct mechanisms of function and regulation is
consistent with their conservation. However, their analysis in the context of a single E2 that collaborates with
only one class of E3s provides the first direct evidence
that the E2 motifs control the robustness and regulation
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Figure 6 GstCka2 inhibits synthesis of free polyubiquitin chains by Cdc34 constructs. (A). Effects of GstCka2 on Sic1 ubiquitination and
synthesis of free polyubiquitin chains by Cdc34 proteins. 5 pmol of Cdc34 or tmCdc34 were phosphorylated at 25°C for 1 hour, as in 5B. The
assays were then supplemented with 1 pmol E1, 660 pmol of ubiquitin, 2 pmol of FlagSCFCdc4 and 2 pmol of Sic1/Cln5/GstCdc28, where
indicated, and incubated at 25°C for the times indicated, followed by a-Sic1 and a-Ub WBs. (B). Ectopic expression of Ubp14 or Ubp15C354A does
not rescue growth of tmCDC34 cka2Δ yeast. The heterozygous diploid RC174 was transformed with the indicated plasmids that overexpress
Ubp14 (pUBP14) or catalytically inactive Ubp14 (pUBP14-C354A) from the ADH1 promoter. These transformed diploids as well as RC173 were
patched onto sporulation media and incubated at 26°C for five days. Haploids with the indicated genotypes were selected by streaking the
heterozygous diploids on haploid selection media with G418 and nourseothricin. Plates were incubated at 30°C for three days.
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Figure 7 Summary Model. The model emphasizes that tmCdc34 is functional in substrate monoubiquitination but has a defect in the synthesis
of substrate-attached and free polyubiquitin chains. This emphasis does not mean that tmCdc34 cannot synthesize polyubiquitin chains. Rather,
it emphasizes that long polyubiquitin chains cannot be synthesized in the short time frame normally available for their synthesis in vivo. Cdc34 is
marked blue; SCFCdc4 is marked navy blue; Sic1 substrate is marked red; the free form of ubiquitin (Ub) is marked white; the ubiquitin-thiolester
is marked yellow; the ubiquitin engaged in isopeptide bond (with substrate or other ubiquitin molecules) is marked green. Black arrows indicate
a robust (three arrows), or modest (one arrow) synthesis of polyubiquitin chains. Green arrow indicates monoubiquitination.

of polyubiquitination. What predictions could be made
based on this finding for the role and regulation of
other E2s? The most obvious prediction is that the alternative motif would support well the function of the E2s
that catalyze monoubiquitination, a process that is not
related to protein degradation but yet regulates several
aspects of cell biology, including endocytosis [42], chromatin remodeling [43] and DNA damage response
[44,45]. An example of such an E2 is Rad6, which
monoubiquitinates histones and PCNA. The second prediction is that the alternative motif has the potential to
support not only monoubiquitination, but also polyubiquitination, at least in reactions with some E3 partners.
However, the mechanism of polyubiquitination catalyzed
in a manner dependent on each motif would be different. In support of this possibility, two major self-oligomerization schemes linked to an activation of
polyubiquitination emerge from analyses of the E2s that
differ in their motifs. The Cdc34/Ubc7-like Ube2g2 E2
self-oligomerizes via a RING-independent interaction
with its gp78 E3 partner [46]. In contrast, the Ubc5-like
E2s, which carry the K73/D97/no loop motif, self-oligomerize in a way dependent on the RING domain and
non-covalent binding between ubiquitin and several
residues located opposite the active site [47-50]. Finally,

Cdc34 has a high preference for lysine K48 that is independent of its SCF E3 partner [51-53], but other E2s
have lower intrinsic fidelity in lysine selection and frequently collaborate with E3s that define the lysine specificity [53,54]. The low intrinsic fidelity in lysine
selection could thus be an evolutionary adaptation that
is associated with the K73/D97/no loop motif and that
allows the synthesis of different linkages depending on
the E3 context. In this view, the alternative motif could
have evolved to provide a basis for the diversity of polyubiquitin linkages and signaling, while the original motif
would have been selected based on the robustness of
K48-type of polyubiquitination.
If the motif replacement in Cdc34 lowers the fidelity
of lysine selection during polyubiquitin chain synthesis
and SCFCdc4 did not evolve to correct for this change,
then polyubiquitin chains synthesized by tmCdc34 could
have altered and/or branched linkages instead of, or in
addition to, the K48 type of polyubiquitin typical for
Cdc34. This model could explain why tmCDC34 yeast
are sensitive to loss of Ubp14, which is the only DUB
that cleaves polyubiquitin in a manner independent of
the Ub-Ub linkage [55,56], and why DUBs other than
Ubp14 disassemble polyubiquitin conjugates less efficiently when they are produced in tm CDC34 cell
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extracts. A similar delay could cause ubiquitin depletion
and/or create conditions under which abnormal polyubiquitin chains potently block the proteasome even without massive accumulation [53]. Ubp14 function is not
required in yeast [[38], this work], but an inhibition of
ubiquitin receptors at the proteasome by an excess of
free polyubiquitin [57] is thought to be responsible for
the developmental defects associated with Ubp14
absence in multi-cellular organisms, including D. discoideum [58] and A. thaliana [59].
What linkages are present in polyubiquitin chains
synthesized by tmCdc34 protein in vitro and in vivo, and
whether the same linkages are present in substrateattached and free polyubiquitin are yet unknown. These
questions would best be addressed by quantitative mass
spectrometry, as ubiquitin mutants could additionally
affect the already fragile tmCdc34/SCF interaction interface (Figure 1B and 1C), which is sensitive to loss of
phosphorylation within the C-terminus of tmCdc34 and
does not properly respond to the regulation by substrate
recruitment. What is the basis of the functional communication between the seemingly independent E2 and
substrate-interacting domains of SCF Cdc4 is yet
unknown, but a similar communication is suggested by
the observation that substrate recruitment promotes
modification of the Cul1 homologue of Cdc53 with the
Nedd8 ubiquitin-like protein, leading to E2 activation
[60]. Phosphorylation would potentiate the acidic nature
of the C-terminus, but how the C-terminus of Cdc34 or
tm
Cdc34 participates in the mechanism of polyubiquitination is also unclear, as the C-terminus is absent from
all known E2 structures (Figure 1C, gray arrow). Why is
Cka2, and not Cka1, essential in tmCDC34 yeast if each
kinase phosphorylates the six most C-terminal serines in
tm
Cdc34 in vitro? Cka1 and Cka2 could differ in their
times or levels of expression, or localizations, or an
undefined feature could give Cka2 a regulatory advantage in tmCDC34 cells.
Perhaps the most interesting question raised by our
study is why the Cdc34/Ubc7-specific motif evolved at all
if its replacement in Cdc34 has only a minimal effect on
cell growth and division? It is possible that either motif
can support Cdc34 function under typical laboratory
conditions, but the mechanism defined by the original
motif is better for survival under sub-optimal and/or
stress conditions. As the only E2 essential for yeast viability and an E2 that has the largest number of substrates
known, Cdc34 would likely be required to function under
a variety of growth conditions. However, we cannot eliminate the possibility that the motif conservation reflects
its ability to undergo post-transcriptional regulation that
controls Cdc34 activity and/or levels. This possibility is
suggested by the presence of serine residues in the S73/
S97/loop motif and by the finding that the steady-state
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level of tm Cdc34 is increased by about four-fold in a
strain isogenic to CDC34 yeast. This change is significant,
as the steady-state levels of Cdc34 do not change during
the cell cycle [5] and are unaffected by replacement of all
lysines to arginines that prevents autoubiquitination [28].
Furthermore, even a five-fold enrichment of Cdc34 in
mammalian cells is sufficient to inhibit an association of
CENP-E with kinetochores and to either delay or block
metaphase alignment of chromosomes [61,62]; and a
similar 4-fold accumulation of Cdc34 has been linked to
the development of pediatric T-cell acute lymphoblastic
leukemia [63]. If such a modest increase in Cdc34 levels
disregulates cell growth and division, a role of the S73/
S97/loop motif in the control of Cdc34 activity and/or
levels could play a role in its conservation. It will be of
great interest to determine what aspect of the catalytic
E2 motif function and/or regulation is responsible for its
conservation.

Conclusions
Replacement of the catalytic S73/S97/loop motif that is
conserved among all members of the Cdc34/Ubc7
family with the K73/D97/no loop motif present in other
E2s compromises the polyubiquitination activity of
Cdc34 in vitro and in vivo, and alters its regulation.
However, either motif can support the essential function
of Cdc34 in cell growth and division, at least under typical laboratory conditions, raising the question of what is
the basis for the motif conservation. We discuss the
possibility that growth under suboptimal and/or stress
conditions, or a requirement for stringent regulation of
Cdc34 levels via the serine residues present in the motif
could explain the motif conservation. We predict that
future analysis of the cellular pathways that are sensitive
to the motif replacement will answer the question of the
motif conservation and may define new roles and/or
regulatory aspects of Cdc34. The essential role of Cka2,
Rpn10 and Rad23 in tmCDC34 yeast [22] also opens the
possibility to define the still enigmatic role of these
cofactors in the SCF-proteasome pathway.
Materials and methods
Yeast Strains and their construction

All strains and their full genotypes are listed in Table 1.
Standard methods were used for strain construction
[64]. Strains RC171, RC172, RC173, and RC174 were
constructed as described in [22].
Plasmids

see Table 2.
Antibodies

We used a-FLAG M2 and a-Ub (Sigma), a-Ub and aHA (Covance), a-Cdc34 [28], a- MBP Sic1, a- Gst Rpn10
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Table 1 Yeast strains used in this study
Strain

Genotype

Reference

862

MATa dsk2::KanR his3Δ1 leu2Δ0 met15Δ0 ura3Δ0

[73]

3195

MATa ubp14::KanR his3Δ1 leu2Δ0 met15Δ 0 ura3Δ0

[73]

R

13195

MATa ubp14::Kan his3Δ1 leu2Δ0 met15Δ0 ura3Δ0

[73]

BL2

MATa

[22]

EJ758
(YIL035c)

MATa his3-Δ200 leu2-3,112 ura3-52 pep4::HIS3 pYEX4T-+rec::CKA1

[74]

EJ758
(YOR061w)

MATa his3-Δ200 leu2-3,112 ura3-52 pep4::HIS3 pYEX4T-+rec::CKA2

[74]

FY24

MATa ura3-52 trp1-Δ63 leu2-Δ1

F. Winston
F. Winston

FY78

MATa his3Δ200

KS418

MATa CDC34tmura3 leu2 trp1 lys2 ade2 ade3

[22]

MT1901

MATa mfa1Δ::pMFA1-HIS3 can1Δ ura3Δ0 leu2Δ0 his3Δ1 lys2Δ0

M. Tyers

RC6

MATa CDC34tm(NAT1) ura3 leu2 trp1 ade2 ade3

[22]

RC21

MATa/a CDC34tm(NAT1)/CDC34 ura3/ura3 leu2/leu2 trp1/TRP1 lys2/LYS2 ade2/ADE2 ade3/ADE3 his3/HIS3 MFA1/mfa1Δ::
pMFA1-HIS3 can1/CAN1

[22]

RC29

MATa cdc34tm(NAT1) mfa1Δ::pMFA1-HIS3 his3Δ ura3Δ leu2Δ can1Δ

[22]
[22]

RC94

MATaCDC34(NAT1) mfa1Δ::pMFA1-HIS3 his3Δ1 leu2Δ0 ura3Δ0 can1Δ

RC85

MATa CDC34tm(NAT1)

[22]

RC171

MATa/a CDC34tm(NAT1)/CDC34 ubp14::KanR/UBP14 mfa1Δ::pMFA1-HIS3/MFA1 his3Δ/his3Δ ura3/ura3Δ0 leu2/leu2Δ0 can1/
CAN1 met15Δ0/MET15

This study

RC172

MATa/a CDC34(NAT1)/CDC34 ubp14::KanR/UBP14 mfa1Δ::pMFA1-HIS3/MFA1 his3Δ/his3Δ ura3/ura3Δ0 leu2/leu2Δ0 can1/CAN1
met15Δ0/MET15

This study

RC173

MATa/a CDC34tm(NAT1)/CDC34 cka2::KanR/CKA2 mfa1Δ::pMFA1-HIS3/MFA1 his3Δ/his3Δ ura3/ura3Δ0 leu2/leu2Δ0 can1/CAN1
met15Δ0/MET15

This study

RC174

MATa/a CDC34(NAT1)/CDC34 cka2::KanR/CKA2 mfa1Δ::pMFA1-HIS3/MFA1 his3Δ/his3Δ ura3/ura3Δ0 leu2/leu2Δ0 can1/CAN1
met15Δ0/MET15

This study

RC175

MATa/a CDC34tm(NAT1)/CDC34 rps7b::KanR/RPS7B mfa1Δ::pMFA1-HIS3/MFA1 his3Δ/his3Δ ura3/ura3Δ0 leu2/leu2Δ0 can1/CAN1 [22]
met15Δ0/MET15

RC176

MATa/a CDC34(NAT1)/CDC34 rps7b::KanR/RPS7B mfa1Δ::pMFA1-HIS3/MFA1 his3Δ/his3Δ ura3/ura3Δ0 leu2/leu2Δ0 can1/CAN1
met15 0/MET15

[22]

YL10-1

MATa cdc34-2 leu2Δ1 ura3-52 trp1Δ63 his3Δ Gal+

[17]

and a- Gst Skp1 [65]. Antibody detection was by ECL
(Amersham).
Recombinant proteins and protein complexes

We used: apyrase, ubiquitin and methylated ubiquitin
(Sigma); Lys48-linked multiubiquitin chains and Isopetidase
T (Enzo Research); yeast Uba1His6 [9]; baculoviruses expressing yeast Sic1, Clb5, Cln2HA, GstCdc28, Cdc53, Rbx1, Cdc4,
Gst
Skp1, FlagSkp1 [8,10], and HAMet30 [33]; C-terminal His6

fusion (pET21+; Novagen) of full length Cdc34 [29],
Cdc34 (triple mutant with the K73/D97/Δ12 instead of
the S73/S97/loop motif, this work), Cdc346SA (with S207,
216, 263, 268, 282 and 292A replacements) [23]; Cdc34244
terminated at residue 244 [29], tmCdc34244 and Δ12Cdc34244
(this work); S207,216A Cdc34244, tm,S207,216Cdc34244,
C95A
Cdc34, S97ECdc34, Cdc34170, Rad6 (this work).
SCF, Sic1 and Cln2 complexes were assembled by coinfecting SF9 insect cells (Invitrogen) for 40 hours with
tm

Table 2 Plasmids used in this study
Plasmid

Description

Reference

pYL150

2μm, LEU2, Ampr, GAL10 promoter +CDC34

[17]

pYL19

pYL150 with S97D mutation in CDC34

[17]

pYL27

pYL150 with 12-residue deletion of G-103 to T-114 in CDC34

[17]

pYL29

pYL150 with 12-residue deletion of G-103 to T-114 and S73K and S97D mutations in CDC34

[17]

pUBP14

ADH1 promoter and terminator elements + UBP14 in pVT102-U

[38]

pUBP14-Ala354

ADH1 promoter and terminator elements +catalytically inactive UBP14(C354A) mutant in pVT102-U

[38]
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the appropriate baculoviruses, followed by cell lysis and
immunoprecipitation [8]. Sic1 was phosphorylated as
described previously [8].
All His-tagged proteins were expressed in E. coli
(BL21 DE3 LysS) and purified on NTA resin (Qiagen)
followed by DEAE and HPLC gel filtration chromatography on Superdex 200 (Amersham) in U buffer (50 mM
Tris, pH 7.5, 50 mM KCl, 0.2 mM DTT).
Gst
Cka1 and GstCka2 kinases were purified from yeast
extracts prepared from cells harvested after 3 hours of
treatment with 1 mM CuS04 during logarithmic growth
on SD URA medium and blast-frozen in a 1:0.7 ratio of
U buffer with 10% glycerol, protease and phosphatase
inhibitors. 1 mg of total proteins was diluted to 1 ml
with N buffer (50 mM Tris, pH 7.5, 150 mM NaCl,
0.5% Igepal, 0.1 mM DTT with protease and phosphatase inhibitors), incubated at 4°C with 20 μl of G SH
Sepharose (Sigma) for 30 minutes, followed by beads
wash, equilibration with U buffer and elution with 40
mM gluthation in buffer U, leading to ~10 ng/μl of
Gst
Cka1 or GstCka2.
Ubiquitination and phosphorylation in vitro

Ubiquitination was performed at 25°C for 1 hour or as
indicated in 10 μl containing buffer U with 1 mM ATP,
1 mM MgCl 2 , 1 pmol of Uba1, 660 pmols of Ub, 2
pmol of FlagSCFCdc4 or GstSCFMet30 (where indicated), 2
pmol of Sic1/Cln5/GstCdc28 or FMet4 substrate (where
indicated), and 1-5 pmol of the indicated Cdc34 proteins
as specified in figures. For phosphorylation the assays
included buffer U with 10 μM ATP and [ 32 P] ATP
(ICN) as indicated, the indicated E2 protein constructs,
and GstCka1 or GstCka2. The reactions were analyzed by
WB or autoradiography.
Preparation of yeast extracts with active ubiquitinproteasome system

Yeast were grown at 30°C in 2 liters of YPD medium
[64] starting from OD 0.05 and harvested in the logarithmic phase of growth. Yeast extracts (5-10 mg/ml
proteins) were prepared by grinding cells blast-frozen in
a 1:0.7 ratio of cells to buffer U (50 mM Tris, pH 7.5;
50 mM KCl; 0.2 mM DTT). The aliquots of extract
were frozen in liquid nitrogen and used immediately
after thawing. Note that this method does not preserve
polyubiquitin conjugates that have been made in cells
prior to lysis, because upon cell lysis in the absence of
protease inhibitors the polyubiquitin conjugates are
either degraded by the proteasome or disassembled by
ubiquitin proteases.
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(150 μl) SDS-PAGE loading buffer with b-mercaptoethanol for 4 minutes at 100°C. Under such conditions,
most proteins, including the proteasome and ubiquitin
proteases (DUBs) are rapidly inactivated, therefore preserving polyubiquitin conjugates that were present in
cells prior to lysis.
Western blot detection of super-stoichiometric amounts
of free polyubiquitin chains

The sensitivity of Western blot detection is restricted by
the concentration of the antibodies and the time of their
incubation with the antigen-bearing membrane. Western
blot performed with high concentrations of a-Ub antibodies (1:100 dilution) and/or for long incubation times
(> 2 hr) allows detection of even small amounts of ubiquitin (~100 pmol). Western blot performed with low
concentration of a-Ub antibodies (1:5000) and short
incubation times (< 30 minutes) can detect only large
amounts (μmol) of the same antigen. By varying these
parameters, we established western blot conditions that
allow detection of polyubiquitin chains only in amounts
exceeding the amount of polyubiquitinated Sic1 (2
pmol), Cdc34 (a fraction of 4 pmol) and/or SCF subunits (a fraction of 2 pmol) in the reaction mixtures that
were independently verified to contain polyubiquitinated
Sic1, Cdc34 and/or SCF subunits via western blots performed with the more sensitive a-Sic1, a-Cdc34, aCdc4 or a-Cdc53 antibodies. The inability of western
blots with a-Ub antibodies to detect polyubiquitinated
Sic1, Cdc34 and/or SCF therefore serves as an internal
control, which verifies that the a-Ub Western blots
allow detection of only super-stoichiometric amounts of
polyubiquitin conjugates. The free nature of these polyubiquitin conjugates is independently verified by their
sensitivity to IsoT (see IsoT sensitivity assays).
Isopeptidase T sensitivity assays

Ubiquitination reactions were performed for 1 hour in
the presence of ATP/MgCl 2 , Uba1, Ub, full length
Cdc34 and SCFCdc4 but not Sic1. 50% of the total ubiquitination mixtures were then incubated at 25°C for 10
minutes with apyrase (0.5 unit), which by hydrolyzing
ATP prevents function of the Uba1 E1 and stops ubiquitin conjugation, followed by enriched with DTT (10 mM
final) and incubation with Isopeptidase T (0.5 mg) for
additional 0-30 minutes. The reactions were stopped by
boiling with SDS-PAGE loading buffer, separated by
SDS-PAGE and analyzed by western blot with a-Ub
antibodies.
Structural modeling

Detection of ubiquitin conjugates in yeast cells

To assess the steady-state levels of ubiquitin conjugates
in cells, yeast cells (2.5 × 10 8) were boiled directly in

Structural models of the E2 core (a.a. 1-170) of Cdc34
and tmCdc34 are shown in the context of structures of a
scRad6 (gray ribbon representation; PDB ID 1AYZ; [66])
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and scUbc7 fragment (gray ribbon representation; PDB
ID 2UCZ; [67]). To model the ubiquitin-charged Cdc34
(a.a. 1-170) bound to the RING domain of Rbx1, scUbc7
structure (dark blue; PDB ID 2UCZ; [67]) was first
superimposed with the structure of Ubc1 (light blue)
charged with ubiquitin (green; PDB ID 1FXT; [68]) and
with the structure of hUbc7 (not shown) in complex
with the RING of c-Cbl (not shown; PDB ID 1FBV;
[69]). The RING domain of c-Cbl was then used to
position the RING domain Rbx1 in complex with Cul1
(red and yellow, respectively; PDB ID 1LDK; [70]). Note
that the E2 core domain (a.a. 1-170) used for modeling
does not include the 39 a.a. (a.a. 171-209) C-terminal
fragment unique to Cdc34 that would extend from the
alpha helix marked with a gray arrow. The amino acid
numbers refer to the position of the residues in Cdc34.
Models were done with the ICM program [71].
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4.
5.

6.

7.

8.

9.

10.

11.

Cell cycle distributions

Yeast cells were analyzed by flow cytometry for their
DNA content using propidium iodide staining [72].
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